Innovation in medical devices as response to Europe's healthcare challenges. Industry's viewpoint

Transcription

1 HIGH-LEVEL CONFERENCE "EXPLORING INNOVATIVE HEALTHCARE THE ROLE OF MEDICAL TECHNOLOGY INNOVATION AND REGULATION" Innovation in medical devices as response to Europe's healthcare challenges Industry's viewpoint Heinrich von Wulfen COCIR President Senior Vice President, Global Sector Sales, Siemens AG, Healthcare Sector Tuesday, 22 March 2011, Brussels

2 Challenges million deaths from chronic disease 60% of all deaths result from chronic disease Deaths from chronic disease will increase by 17% by mm Chronic disease deaths Worldwide 7.6mm 4.1mm Cardiovascular diseases Cancer Chronic respiratory disease 1.4mm Diabetes

3 Innovation in Medical Devices Diagnostics Biotech & Genomics IT & bioengineering Faster, accurate imaging Molecular imaging Minaturisation/portability Point of Care diagnostics Therapy selection/monitor Targeted therapy Proteomics/DNA Biomarkers Rapid screening tools Vaccine development ehealth/telemedicine Mobile solutions BioSensors Computer Aided Diagnostics Patient monitoring

4 Changing Role of Healthcare Imaging Trend: Minimal invasive procedures (i.e. more gentle methods for the elderly) more images for guiding Therapies than Diagnostic procedures Trend: Increasing number of IVD tests Imaging tells the where Request for Screening: One-third of all cancers could be cured if detected and treated early earlier detection followed by less costly treatment / therapy Trend: Personalized Medicine Biomarker research & imaging to characterize disease fundamentals

5 Call for attention to public authorities Innovative technology as long-term investment EU and the Members States as drivers of implementation and uptake of innovative technology Need to accelerate adoption of new methods and technologies into clinical practice Healthcare authorities should translate faster innovation from research to market Public procurement and reimbursement systems should incentivise innovative technologies and IT connectivity Hospital Community clinic Home Utilization PRESENT FUTURE High Acuity Low

6 Funding Simplify framework programs and enhance access to funding to promote innovative healthcare Need to optimise the use of structural funds in health and heathcare innovations Research funding should not neglect applied innovations The EU Research and Innovation landscape and its funding should focus more on supporting innovations that can address societal challenges Lack of long term planning of ehealth funding

7 Leverage the Power of Healthcare IT Healthcare IT and ehealth proven high clinical and societal value Government Polyclinic Hospital Telehealth linking patients with care providers Pharmacy Home Central Patient s EHR IT infrastructure ensure that systems derive maximal value from medical technology (Cloud computing) Laboratory IT connectivity through IHE (Integrating the Healthcare Enterprise) improving quality and reducing cost More investment in ehealth bestpractice clinical pathways / patient s mobility throughout Europe

8 Conclusions Supportive Regulatory System: Predictable, cost-efficient regulatory processes to consolidate the EU leadership position in medical device innovation and give patients rapid access Prevention: Paradigm shift needed towards a more preventive, patient-centered care Short & Long term investment: Deployment of innovative healthcare & IT technologies is crucial for sustainability of healthcare systems

9 Background slide

10 Our Industry Key Figures Global Market of 80+ billion: Europe 35% Strong & continuous market growth: 5 8% on average No single European market, USA is largest market Global leaders are headquartered in Europe Around 8% of revenues are reinvested in R&D Competitive R&D platforms in the USA, Europe and Japan Day-to-day facts: Healthcare Information systems touch every patient many times along the continuum of care One out of two patients in a hospital is imaged